Flunitrazepam excretion patterns using the abuscreen OnTrak and OnLine immunoassays: Comparison with GC-MS

Journal of Analytical Toxicology

Volumn 21, Issue 5, 1997, Pages 341-345

  Salamone, S J ^a   Honasoge, S ^a   Brenner, C ^a   McNally, A J ^a   Passarelli, J ^a   Goc Szkutnicka, K ^a   Brenneisen, R ^b   ElSohly, M A ^c   Feng, S ^c  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c ElSohly Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DRUG METABOLITE; FLUNITRAZEPAM;

ADULT; ARTICLE; DRUG ABUSE; DRUG DETERMINATION; DRUG EXCRETION; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; URINALYSIS;

EID: 0030841642     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.5.341     Document Type: Article

References (12)

1. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man. 4th ed. Chemical Toxicology Institute, Foster City, CA. 1995. pp 325-27.
2. O.H. Drummer, M.L. Syrjanen, and S.M. Cordner. Deaths involving the benzodiazepine flunitrazepam. Am. J. Forensic Med. Pathol. 14: 238-43 (1993).
3. S.H. Calhoun, D.R. Wesson, G.P. Galloway, and D.E. Smith. Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and South Texas. J. Psychoactive Drugs 28: 183-89 (1996).
4. A. Boukhabza, A.A.J. Lugnier, P. Kintz, and P. Mangin. Simultaneous HPLC analysis of the hypnotic benzodiazepines nitrazepam, estazolam, flunitrazepam, and triazolam in plasma. J. Anal. Toxicol. 15: 319-22 (1991)
5. R. Meatherall. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required. J. Anal. Toxicol. 18: 385-90 (1994).
6. A.D. Fraser. The benzodiazepines: a controversial class of drugs in the 1990s. AACC In-Service Training and continuing education. Washington, D.C. 13: 7-13 (1992).
7. O. Beck, P. Lafolie, P. Hjemdahl, S. Borg, G. Odelius, and P. Wirbing. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis in urine: two techniques evaluated and modified for improved performance. Clin. Chem. 38: 271-75 (1992).
8. G. Wendt. Schicksal des Hypnotikums Flunitrazepam im menschlichen Organismus. In Bisherige Erfahrungen mit Rohypnol (Flunitrazepam) in der Anasthesiologie und Intensivtherapie. W. Huegin, G. Hossli, and M. Gemperle, Eds. Hoffmann-La Roche, Basel, Switzerland, 1976. pp 27-38.
9. O. Beck, P. Lafolie, G. Odelius, and L. Boréus. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol. Lett. 52: 7-14 (1990).
10. P. Simonsson and S. Lindberg. Effect of β-glucuronidase on urinary benzodiazepine concentration determined by fluorescence polarization immunoassay. Clin. Chem. 41: 920-23 (1995)
11. M.A. ElSohly, S. Feng, S.J. Salamone, and R. Wu. A sensitive GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine. J. Anal. Toxicol. 21: 335-10 (1997).
12. H.C. Walls, B.W. Steele, R. Maclure, and W.L. Hearn. The confirmation of benzodiazepines in DUI cases by GC-MS. Abstract. J. Anal. Toxicol. 21: 85 (1997).